Altered liver expression of IGFBP1 and G6P has been reported in patients with NASH [20,21] and metallothioneins may play preventive roles against obesity through reduction of oxidative stress. This evidence concerns the gene IGFBP1 and metabolic dysfunction-associated steatohepatitis.